pharmaphorum

DECEMBER 11, 2022

Digital transformation in pharma is not a singular endeavour. It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations.

Clinical Research 137

Clinical Research Life Science Medicine Radiology 137

Pharmaceutical Technology

DECEMBER 21, 2022

Artificial intelligence (AI) continued to stay in the news with several high-profile deals this year, as the pharmaceutical industry readily took to adopting AI models to improve drug discovery. But as the field grows in leaps and bounds, many authorities have prioritised the release of new guidelines, frameworks, and regulations to keep pace with these advances.

Regulation 351

Regulation Pharma Companies Clinical Trials Clinical Trials 351

Bio Pharma Dive

DECEMBER 19, 2022

The OK caps a long development journey for the treatment, which was previously turned back by the agency. Ferring doesn’t expect it to be available until the second half of next year, however.

Gene Therapy 353

Gene Therapy FDA Approval Gene Development 353

NPR Health - Shots

DECEMBER 31, 2022

Since the return of the Taliban, Afghanistan's coal exports have increased — and so has child labor. At a coal mine in Baghlan province, boys earn between $3 and $8 for a day's work.

145

145

Advertisement

There’s been a rapid shift towards decentralization in clinical trials & it’s clear why. The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. Tele visits, digital consent, new monitoring sensors, & direct-to-patient supply are virtual tools that existed before the pandemic, but now there’s swift adoption of these methods because they’ve been proven to help launch & complete trials more effectively.

Trials

STAT News

DECEMBER 20, 2022

Lots of people struggle to get enough sleep — and the responsibility for fixing the problem tends to fall on the individual. Experts offer advice like reducing screen time, exercising more, or just going to bed earlier in the evening. But many restless nights can’t be solved with blackout curtains, ear plugs, or other typical suggestions.

145

145

Medical Xpress

DECEMBER 20, 2022

Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.

Medicine 145

Medicine Development Research Cardiology 145

Pharmaceutical Technology

DECEMBER 21, 2022

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. The latest development comes after the parties announced an agreement in principle in June this year. This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure.

Gene Therapy 351

Gene Therapy Vaccination Vaccine Gene 351

Bio Pharma Dive

DECEMBER 6, 2022

In an interview with BioPharma Dive, the longtime industry executive discussed becoming a biotech investor and his plans for Abio-X, a new incubator with $150 million to spend on startups.

348

348

NPR Health - Shots

DECEMBER 15, 2022

Scientists predict China will see the largest COVID surge of the pandemic this winter, with hundreds of millions of people infected. But some experts say that it could have been even worse.

Scientist 145

Scientist 145

STAT News

DECEMBER 14, 2022

Hospice in America is gravely ill. An extensive investigation jointly published by The New Yorker and ProPublica documented outright fraud, predatory practices, and flagrant mistreatment by specific publicly traded and private equity-owned hospice companies.

145

145

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Medical Xpress

DECEMBER 20, 2022

Probiotic bacteria usually found in fermented foods, such as yogurt, sourdough bread, and miso soup, might help dispel the embarrassment of persistent bad breath (halitosis), finds a pooled data analysis of the available evidence, published in the open access journal BMJ Open.

Bacteria 145

Bacteria 145

BioPharma Reporter

DECEMBER 19, 2022

Replay, the genome writing company reprogramming biology by writing and delivering big DNA, has launched its third product company, Kaleibe, a HSV gene therapy company targeting genetic brain disorders.

Gene Therapy 134

Gene Therapy Genetics Gene Genome 134

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The companies entered the initial agreement in September last year. This alliance is utilising the Axiomer ribonucleic acid (RNA) editing platform of ProQR to address ailments affecting the liver and nervous system.

Genetics 328

Genetics Medicine Gene Therapy RNA 328

Bio Pharma Dive

DECEMBER 12, 2022

After outlasting rival suitors Sanofi and J&J in deal talks, Amgen agreed to a deal that values the Ireland-based maker of rare and inflammatory disease drugs at about $28 billion.

Drugs 345

Drugs 345

Advertiser: FourKites

A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.

Research

NPR Health - Shots

DECEMBER 15, 2022

People are gathering indoors for the holidays, and there's been an uptick in COVID-19 cases. The federal government says you should test often to try to prevent the spread of the virus.

145

145

STAT News

DECEMBER 14, 2022

Almost 90% of the health care companies deemed to be under financial stress by a leading credit rating agency are owned by private equity , a stark indicator of the toll financial investors have taken on a vital sector. The striking finding is part of a new Moody’s Investors Service report released this week that shows broad turbulence throughout an industry weakened by private equity’s practice of loading companies with debt, making them less resilient to challenges like Covid-19,

145

145

Medical Xpress

DECEMBER 12, 2022

Reasons underlying hesitancy to get vaccinated against COVID-19 may be associated with increased risks of traffic accidents according to a new study in The American Journal of Medicine. Researchers found that adults who neglect these health recommendations may also neglect basic road safety. They recommend that greater awareness might encourage more COVID-19 vaccination.

Vaccination 145

Vaccination Vaccine Medicine Research 145

pharmaphorum

DECEMBER 16, 2022

CSL’s gene therapy for haemophilia B has been recommended for approval by the EMA’s human medicine committee, setting up a decision by the European Commission early next year. The positive opinion for etranacogene dezaparvovec – which was approved as Hemgenix by the FDA last month – raises the prospect of the first one-time therapy in the EU for the bleeding disorder, which affects around 1 in 50,000 of the population, according to the European Haemophilia Network (EUHANET).

Gene Therapy 126

Gene Therapy Gene Medicine Trials 126

Speaker: Steve Goldstein, Sales Leader

Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? What are some of the top challenges your customers face and how do you approach understanding what’s most important to them? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., to discover critical strategies and approaches you can take to engage your customers, achieve g

Sales

Pharmaceutical Technology

DECEMBER 15, 2022

Mexico is Latin America’s second-largest pharmaceutical market and ranks in the top 15 on the global list of biggest pharma markets. By 2025, multiple growth factors are contributing to this figure rising to a projected $30.04bn, according to GlobalData analysis. In addition, more than $15.48bn in pharma sales were recorded in Mexico in 2021, and the country offers a strong manufacturing base for antibiotics, analgesics, and antiparasitics.

Manufacturing 321

Manufacturing Clinical Trials Clinical Trials Marketing 321

Bio Pharma Dive

DECEMBER 8, 2022

As the success of drugs like Enhertu catalyzes new investment in antibody-drug conjugates, the California startup is launching with plans to develop more potent versions of the targeted cancer medicines.

Drugs 334

Drugs Antibody Medicine Development 334

NPR Health - Shots

DECEMBER 25, 2022

China's National Health Commission said in a statement it would no longer publish daily data and that "from now on, the Chinese CDC will release relevant COVID information for reference and research.

Research 144

Research 144

STAT News

DECEMBER 10, 2022

Whenever a hematopoietic cell transplant patient tries to get a family member to sneak food in past the nurses, Federico Stella, a resident hematologist at the University of Milan, remembers. One was a girl who tried to get her sister to bring her a panettone, a Milanese sweet bread usually eaten around the holidays. A week before Christmas, the sister tried to hide the panettone in a bag.

Nurses 145

Nurses 145

Advertiser: Aggregage

New vaccine mandates and testing policies will affect employers with more than 100 workers. Get Paycor’s free, customizable vaccination policy template to communicate critical details and new requirements to your employees. Get Paycor’s Template today!

Vaccination

Medical Xpress

DECEMBER 2, 2022

In the older European population, men, as well as those with lower socioeconomic status, weak social ties, and poor health, might experience more difficulties getting informal support and are considered to have a higher risk of worsening frailty state and lower quality of life. This reality is shown in a new doctoral thesis at Umeå university.

Doctors 143

Doctors Doctor Research 143

pharmaphorum

DECEMBER 22, 2022

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna. The government said today it has finalised the partnership – agreed in principle earlier this year and estimated to be worth in the region of $1.2 billion – although it is not revealing the financial details, as these are “commercially sensitive.” The overar

Vaccination 122

Vaccination Vaccine Clinical Trials Clinical Trials 122

Pharmaceutical Technology

DECEMBER 13, 2022

CSL subsidiary CSL Seqirus has closed the international partnership and licence agreement with Arcturus Therapeutics for research, development, production and international marketing of self-amplifying messenger ribonucleic acid (sa-mRNA) vaccines. Under the deal, CSL will gain access to Arcturus’ sa-mRNA vaccine platform technology. In November, the companies announced the strategic partnership.

Vaccination 312

Vaccination Vaccine Gene Therapy Gene 312

Bio Pharma Dive

DECEMBER 12, 2022

Roche’s subsidiary Spark has offered few updates on its hemophilia A treatment since being acquired in 2019. New data at ASH show the therapy can maintain levels of a key blood-clotting protein for years.

Gene Therapy 330

Gene Therapy Gene Protein 330

NPR Health - Shots

DECEMBER 28, 2022

Public health officials want more Americans to get the latest COVID vaccine booster. Only 35% of people over 65 have gotten the shot, though 75% of COVID deaths are among people in this age group.

Vaccination 143

Vaccination Vaccine 143

STAT News

DECEMBER 9, 2022

There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson. The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech.

145

145

Medical Xpress

DECEMBER 13, 2022

Females' propensity to deposit more fat in places like their hips, buttocks and the backs of their arms, so-called subcutaneous fat, is protective against brain inflammation, which can result in problems like dementia and stroke, at least until menopause, scientists report.

Scientist 141

Scientist 141

pharmaphorum

DECEMBER 7, 2022

Elon Musk’s brain computer interface (BCI) company Neuralink is being investigated by law enforcement authorities in the US amid allegations of animal welfare violations in its testing facilities. Neuralink’s BCI is intended to treat conditions like blindness and spinal cord injury, as well as provide a way to interact with digital devices using the brain and, according to Musk, is on the brink of moving into the human testing stage.

Clinical Trials 122

Clinical Trials Clinical Trials Medicine Trials 122

Pharmaceutical Technology

DECEMBER 27, 2022

The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced.

Clinical Trials 306

Clinical Trials Clinical Trials Drugs Trials 306

Bio Pharma Dive

DECEMBER 1, 2022

The regulatory OK, a milestone for microbiome-based drug research, is for a medicine from Ferring Pharma that treats a recurrent type of gut infection.

FDA Approval 358

FDA Approval Medicine Drugs Research 358